Liu X - Search Results

1

Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China.

Yang Y, Zhang Y, Jiang Q, Meng L, Li W, Liu B, Liu X, Zhou L, Liang R, Zhu X, NaXu, Kuang P, Lin T, Zhu H. Yang Y, et al. Among authors: liu x, liu b. Chin Med J (Engl). 2022 Jun 20;135(12):1498-1499. doi: 10.1097/CM9.0000000000001899. Chin Med J (Engl). 2022. PMID: 34966029 Free PMC article. No abstract available.

2

Clinical significance of cytogenetic analysis in chronic myeloid leukemia (with report of 155 cases).

Du QF, Liu XL, Song LL, Zhang S, Zhou SY. Du QF, et al. Di Yi Jun Yi Da Xue Xue Bao. 2002 Oct;22(10):905-7. Di Yi Jun Yi Da Xue Xue Bao. 2002. PMID: 12377614

3

[Application of interphase fluorescence in situ hybridization for determination of the tumor load in chronic myeloid leukemia].

Du QF, Zhou SY, Liu XL, Song LL, Zhang Y. Du QF, et al. Ai Zheng. 2003 Jun;22(6):612-5. Ai Zheng. 2003. PMID: 12948411 Chinese.

4

[Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].

Liu XL, Zhou SY, Du QF, Zheng WY, Zhang S, Song LL, Xu B, Liu QF, Meng FY. Liu XL, et al. Ai Zheng. 2004 Apr;23(4):421-5. Ai Zheng. 2004. PMID: 15087031 Chinese.

5

[Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].

Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY. Liu QF, et al. Ai Zheng. 2004 Apr;23(4):426-9. Ai Zheng. 2004. PMID: 15087032 Chinese.

6

The role of heterogeneous nuclear ribonucleoprotein K in the progression of chronic myeloid leukemia.

Du Q, Wang L, Zhu H, Zhang S, Xu L, Zheng W, Liu X. Du Q, et al. Among authors: liu x. Med Oncol. 2010 Sep;27(3):673-9. doi: 10.1007/s12032-009-9267-z. Epub 2009 Aug 4. Med Oncol. 2010. PMID: 19653139

7

Minimal residual disease monitoring in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation using interphase fluorescence in situ hybridization and real-time quantitative reverse transcription PCR.

Zhu HQ, Liu XL, Song LL, Liu QF, Meng FY, Zhou SY. Zhu HQ, et al. Chin J Cancer. 2010 Feb;29(2):194-7. doi: 10.5732/cjc.009.10250. Chin J Cancer. 2010. PMID: 20109350 Free article.

8

[Clinical significance of CRKL protein phosphorylation level in the treatment of chronic myeloid leukemia with imatinib].

Xu N, Ouyang Z, DU QF, Wang S, Yang J, Wang Y, Liu XL. Xu N, et al. Zhonghua Xue Ye Xue Za Zhi. 2011 Jan;32(1):25-8. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 21429397 Chinese.

9

[Identification of differentially expressed genes related to blastic crisis in chronic myeloid leukemia].

Luo X, Zhang J, Liu X, Du Q, Xu N, Xu L, Huang B, Xiao X. Luo X, et al. Among authors: liu x. Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jun;32(6):840-2. Nan Fang Yi Ke Da Xue Xue Bao. 2012. PMID: 22699066 Chinese.

10

[Bioinformatic analysis of chronic myeloid leukemia progression and preliminary experimental verification].

Zhang JF, Liu XL, Lin YD, Pan JW, Xu N. Zhang JF, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Aug;22(4):909-13. doi: 10.7534/j.issn.1009-2137.2014.04.006. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 25130802 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136,618 results

Search Page

Filters